Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-11-2022 | Paracetamol | Case report

Paracetamol

Hepatotoxicity from supratherapeutic dose following an exposure during pregnancy: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Simon M, et al. Pregnancy associated adverse events in patients treated with therapies for COVID-19 reported to the FDA ACMT COVID-19 ToxIC (FACT) pharmacovigilance project. Clinical Toxicology 60 (Suppl. 2): 18 abstr. 35, 2022. Available from: URL: http://doi.org/10.1080/15563650.2022.2107776 [abstract] Simon M, et al. Pregnancy associated adverse events in patients treated with therapies for COVID-19 reported to the FDA ACMT COVID-19 ToxIC (FACT) pharmacovigilance project. Clinical Toxicology 60 (Suppl. 2): 18 abstr. 35, 2022. Available from: URL: http://​doi.​org/​10.​1080/​15563650.​2022.​2107776 [abstract]
Metadata
Title
Paracetamol
Hepatotoxicity from supratherapeutic dose following an exposure during pregnancy: case report
Publication date
01-11-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-27277-3

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Tozinameran

Case report

Doxylamine

Case report

Duloxetine

Case report

Thiocolchicoside